FDA approves the first subcutaneous version of nivolumab, making PD-1 inhibitors available to new groups of patients.

Opdivo Qvantig is the first subcutaneously administered PD-1 inhibitor approved by the FDA. It is expected to be available in ...

Daiichi Sankyo has signed a deal worth up to $300 million with South Korean biotech Alteogen to develop a subcutaneous version of its AstraZeneca-partnered cancer drug Enhertu. Alteogen will ...

alongside a pr Block's expanding partner base and strong positioning in the digital payments industry are driving prospects despite stiff competition and stretched valuation. Investing.com ...

Hangzhou Sino-US Huadong medicine Co., Ltd. (hereinafter referred to as "Huadong Medicine"), a wholly-owned subsidiary of Huadong Medicine Co., Ltd. (SZ.000963), and SynerK PharmaTech (Suzhou) Co., ...

Objectives To investigate the efficacy and safety of short subcutaneous infusions (SSCIs) for refractory symptoms in the palliative setting. Methods A retrospective chart review of SSCIs in a single ...

In late 2020, CDT acquired and verified a collection of propaganda directives issued by central Party authorities to state media at the beginning of that year. These directives were issued on an ...

The tools within social media offer new opportunities to promote pharmaceutical products, but compliance with the FDA remains the stumbling block ... beats MSD to the US subcutaneous PD-1 ...

After hours report provides a review of the day’s stock market and treasury market session performance with a recap of indices, sector, and industry performance, trends, as well as key news items that ...

Welcome to The Block’s 2025 Digital Assets Outlook Report, a comprehensive analysis of the past year’s developments in the cryptocurrency and blockchain space. This report leverages insights across ...

Janet Berry-Johnson, CPA, is a freelance writer with a background in accounting and income tax planning and preparation for individuals and small businesses. Her work has appeared in Business ...

Stay up-to-date with the latest and best audio content from CBC Listen delivered to your inbox every two weeks.